Clinical Trials for Lung Cancer: What They Are and Why You Should Ask Early

Clinical trials can feel intimidating, but they are one of the most important ways new lung cancer treatments become available to patients. In this episode of Hope With Answers: Living With Lung Cancer, patient advocate Wendy Brooks sits down with Dr. Ashish Saxena, thoracic medical oncologist at Weill Cornell Medicine, to break down what clinical trials really are and why they matter. Together, they discuss when patients should ask about clinical trials, what to expect when participating, and common misconceptions — including the fear of being a “guinea pig.” Dr. Saxena explains how clinical trials are carefully designed, closely monitored, and often provide access to promising new therapies earlier in the treatment journey. You’ll learn: What clinical trials are and how they work Why timing matters and why you should ask early What patients actually receive in a clinical trial How clinical trials are improving outcomes in lung cancer What questions to ask your doctor Whether you’re newly diagnosed or exploring your options, this conversation offers clear, practical insight to help you better understand clinical trials and your role in the decision-making process. Show Notes: https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-HWA-Clinical-Trials-Show-Notes-2026Spring.pdf  Transcript: https://lcfamerica.org/wp-content/uploads/2026/04/LCFA-HWA-Clinical-Trials-Transcript-2026Spring.pdf  Watch Video: https://youtu.be/kBfh8EAGey8  To learn more about clinical trials and download the free toolkit, visit https://lcfamerica.org/trials.